NO20005352L - ascorbate - Google Patents
ascorbateInfo
- Publication number
- NO20005352L NO20005352L NO20005352A NO20005352A NO20005352L NO 20005352 L NO20005352 L NO 20005352L NO 20005352 A NO20005352 A NO 20005352A NO 20005352 A NO20005352 A NO 20005352A NO 20005352 L NO20005352 L NO 20005352L
- Authority
- NO
- Norway
- Prior art keywords
- ascorbate
- useful
- treatment
- cns disorders
- certain cns
- Prior art date
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract 4
- 229940072107 ascorbate Drugs 0.000 title abstract 2
- 235000010323 ascorbic acid Nutrition 0.000 title abstract 2
- 239000011668 ascorbic acid Substances 0.000 title abstract 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 abstract 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 229960002296 paroxetine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Paroksetinaskorbat er nyttig ved behandling av visse CNS-lidelser.Paroxetine ascorbate is useful in the treatment of certain CNS disorders.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
| PCT/GB1999/001244 WO1999055698A1 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005352D0 NO20005352D0 (en) | 2000-10-24 |
| NO20005352L true NO20005352L (en) | 2000-10-24 |
Family
ID=10831008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005352A NO20005352L (en) | 1998-04-25 | 2000-10-24 | ascorbate |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1089995A1 (en) |
| JP (1) | JP2002513019A (en) |
| KR (1) | KR20010042977A (en) |
| CN (1) | CN1297448A (en) |
| AP (1) | AP2000001963A0 (en) |
| AU (1) | AU3618499A (en) |
| BG (1) | BG104940A (en) |
| BR (1) | BR9909868A (en) |
| CA (1) | CA2330055A1 (en) |
| EA (1) | EA200001104A1 (en) |
| GB (1) | GB9808896D0 (en) |
| HU (1) | HUP0102116A3 (en) |
| ID (2) | ID26083A (en) |
| IL (1) | IL139081A0 (en) |
| NO (1) | NO20005352L (en) |
| PL (1) | PL343677A1 (en) |
| SK (1) | SK15912000A3 (en) |
| TR (1) | TR200003084T2 (en) |
| WO (1) | WO1999055698A1 (en) |
| ZA (1) | ZA200005912B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| WO2003057650A2 (en) | 2002-01-09 | 2003-07-17 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
| IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
| CN110607553B (en) * | 2018-10-30 | 2024-03-22 | 中国科学院化学研究所 | Method for preparing medicine or medicine intermediate monocrystal or amorphous substance with adjustable particle size |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
| US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
| ES2117557B1 (en) * | 1996-02-29 | 1999-07-01 | Ferrer Int | NEW PROCEDURE FOR OBTAINING (-) - TRANS -N-P-FLUOROBENZOILMETIL-4- (P-FLUOROFENIL) -3- ((3,4- (METHYLENDIOXI) PHENOXI) METHYL) -PIPERIDINE. |
-
1998
- 1998-04-25 GB GBGB9808896.6A patent/GB9808896D0/en not_active Ceased
-
1999
- 1999-04-23 SK SK1591-2000A patent/SK15912000A3/en unknown
- 1999-04-23 IL IL13908199A patent/IL139081A0/en unknown
- 1999-04-23 CA CA002330055A patent/CA2330055A1/en not_active Abandoned
- 1999-04-23 JP JP2000545858A patent/JP2002513019A/en active Pending
- 1999-04-23 ID IDW20002168A patent/ID26083A/en unknown
- 1999-04-23 EA EA200001104A patent/EA200001104A1/en unknown
- 1999-04-23 HU HU0102116A patent/HUP0102116A3/en unknown
- 1999-04-23 EP EP99918151A patent/EP1089995A1/en not_active Withdrawn
- 1999-04-23 KR KR1020007011809A patent/KR20010042977A/en not_active Withdrawn
- 1999-04-23 BR BR9909868-7A patent/BR9909868A/en not_active Application Discontinuation
- 1999-04-23 WO PCT/GB1999/001244 patent/WO1999055698A1/en not_active Ceased
- 1999-04-23 AU AU36184/99A patent/AU3618499A/en not_active Abandoned
- 1999-04-23 ID IDW20002169A patent/ID26654A/en unknown
- 1999-04-23 AP APAP/P/2000/001963A patent/AP2000001963A0/en unknown
- 1999-04-23 TR TR2000/03084T patent/TR200003084T2/en unknown
- 1999-04-23 CN CN99805160A patent/CN1297448A/en active Pending
- 1999-04-23 PL PL99343677A patent/PL343677A1/en not_active Application Discontinuation
-
2000
- 2000-10-23 ZA ZA200005912A patent/ZA200005912B/en unknown
- 2000-10-24 NO NO20005352A patent/NO20005352L/en not_active Application Discontinuation
- 2000-11-13 BG BG104940A patent/BG104940A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR200003084T2 (en) | 2001-02-21 |
| SK15912000A3 (en) | 2001-04-09 |
| ID26083A (en) | 2000-11-23 |
| EA200001104A1 (en) | 2001-04-23 |
| ZA200005912B (en) | 2001-12-19 |
| CN1297448A (en) | 2001-05-30 |
| AP2000001963A0 (en) | 2000-12-31 |
| NO20005352D0 (en) | 2000-10-24 |
| IL139081A0 (en) | 2001-11-25 |
| KR20010042977A (en) | 2001-05-25 |
| PL343677A1 (en) | 2001-08-27 |
| ID26654A (en) | 2001-01-25 |
| GB9808896D0 (en) | 1998-06-24 |
| EP1089995A1 (en) | 2001-04-11 |
| HUP0102116A2 (en) | 2002-05-29 |
| WO1999055698A1 (en) | 1999-11-04 |
| AU3618499A (en) | 1999-11-16 |
| BG104940A (en) | 2001-09-28 |
| BR9909868A (en) | 2000-12-19 |
| CA2330055A1 (en) | 1999-11-04 |
| HUP0102116A3 (en) | 2002-12-28 |
| JP2002513019A (en) | 2002-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20032254L (en) | Compounds for Inhibition of Expression of VACM-I | |
| DE60124684D1 (en) | SULPHONAMIDO-SUBSTITUTED BROKEN BICYCLOALKYL DERIVATIVES | |
| NO975747D0 (en) | Peptidyl heterocycles for use in the treatment of thrombin-related deficiencies | |
| NZ335981A (en) | Ketobenzamides as calpain inhibitors | |
| NO20005885L (en) | Combination therapy for the treatment of refractory depression | |
| NO20005884D0 (en) | Combination therapy for the treatment of bipolar disorders | |
| PT889886E (en) | NEW FENANTRIDINES REPLACED IN POSITION 6 | |
| ZA200107689B (en) | 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders. | |
| YU48698A (en) | Carboxamide derivatives of pyrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorder | |
| ID27214A (en) | TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS | |
| NO20003211D0 (en) | Triazine compounds for the treatment of CNS disorders | |
| NO984432L (en) | Procedure for the treatment of migraine pain | |
| CY1107039T1 (en) | TRIPEPTIDYL PEPTIDASE Suspensions | |
| BR0012921A (en) | Calcally Compounds | |
| BG100248A (en) | SQUALENSENTEZA INHIBITORS | |
| NO990450D0 (en) | Treatment of mental disorders | |
| AP2000001963A0 (en) | Paroxetine ascorbate. | |
| NO20011892L (en) | 3-tetrahydropyridin-4-yl indoles for the treatment of psychotic disorders | |
| DK1133296T3 (en) | New therapeutic use of nicergoline | |
| NO20010390D0 (en) | Treatment of anxiety disorders | |
| NO20010569D0 (en) | Protease inhibitors for use in the treatment of psoriasis | |
| DE69917445D1 (en) | CLEANING CARBOXALDEHYDE | |
| NO992021D0 (en) | Procedure for pulp treatment of wood pulp | |
| EE200200670A (en) | S-methyldihydroziprasidone for the treatment of psychiatric and ocular disorders | |
| YU22802A (en) | Isonipectoamides for the treatment of integrinmediates disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |